Ajax-Loading

Abbott Laboratories - Price To Cashflow Ratio

Abbott Laboratories's Fiscal Year is From January To December.

The item "Price-To-Cashflow-Ratio" stands at 25.16 as of 09/30/2025.

As of the end of Abbott Laboratories's third quarter, the item "Price To Cashflow Ratio" stands at 25.16. This represents a decrease of -0.82 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.40 percent compared to the value the year prior.
The 1 year change in percent is 16.40.
The 3 year change in percent is 59.03.

The Serie's long term average value is 22.22. It's latest available value, on 09/30/2025, is 13.27 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +59.03%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -7.42%.

Price To Cashflow Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoIntuitive Surgical Inc - Price To Cashflow Ratio206,245,888,000.00
LogoEssilorLuxottica S. A. - Price To Cashflow Ratio172,241,486,586.05
LogoDanaher Corporation - Price To Cashflow Ratio162,006,663,168.00
LogoBoston Scientific Corp - Price To Cashflow Ratio144,567,730,176.00
LogoStryker Corporation - Price To Cashflow Ratio139,209,850,880.00